- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01147367
Physical Activity, Fatigue, Sleep, and Inflammation (ABLE)
Physical Activity Benefits After Breast Cancer: Exploring Cytokine Mechanisms
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Our previous research has shown that increases in physical activity can improve the health and well-being of breast cancer survivors. The current study will determine whether the physical activity increases are adequate for improved health by measuring physical activity (accelerometer and self-report), muscle strength, fatigue, and sleep. Moreover, few studies have examined cytokine changes in cancer survivors after participation in a physical activity behavior change intervention with a mechanistic focus on cytokines which may influence the muscle strength, fatigue, and sleep response to the intervention.
Seventy-four female, breast cancer survivors are being recruited within a 50-miles radius of Springfield, IL. Participants will be in the study for approximately 5 months. Participants will be asked to complete a questionnaire at the beginning of the study and 3 months later. A blood sample will be drawn to determine serum cytokine levels.
Volunteers will be randomly assigned to 1 of 2 study groups. The intervention group will participate in a 3 month physical activity intervention involving moderate intensity walking and strength training with resistance bands.
This randomized controlled trial includes the following study aims:
Study aim 1: The intervention group will be compared with the control group to examine the change in physical activity, muscle strength, fatigue, and sleep dysfunction before and after participation in a physical activity intervention.
Study aim 2: To investigate mechanisms that may underlie the effects of the physical activity intervention on muscle strength, fatigue, and sleep, we will compare the intervention group with the control group in terms of changes in cytokine markers of inflammation and evaluate whether such changes are consistent with and may mediate changes in muscle strength, fatigue, and sleep dysfunction.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Illinois
-
Springfield, Illinois, Forente stater, 62702
- Southern Illinois University School of Medicine
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Female, 30 to 70 years of age, with first diagnosis of ductal carcinoma in situ (DCIS) or Stage I or Stage II breast cancer
- If chemotherapy or radiation therapy was received, the patient must be at least 4 weeks status post final primary treatment administration to allow treatment related cytokine changes to resolve. The participant may be taking longer term therapies such as aromatase inhibitors, estrogen receptor modulators, etc.
- If the patient has undergone a surgical procedure, she must be at least 8 weeks post-procedure.
- English speaking
- Medical clearance for participation provided by primary care physician or oncologist
- Postmenopausal
- Average fatigue over the past week of ≥ 3 on a 1 to 10 Likert scale or sleep dysfunction ≥ 1 on a 0 to 3 Likert scale
- Participating, on average, in no more than 20 minutes of physical activity on two or fewer days per week during the past six months
- Willing to abstain from "as needed" medications for 7 days prior to each blood draw. "As needed" medications are defined as any medicine (prescription or over-the-counter) that is taken sporadically as needed for specific complaints rather than taken at regularly scheduled intervals (e.g., daily).
Exclusion Criteria:
- Metastatic or recurrent breast cancer
- Inability to ambulate without assistance
- Unstable angina
- New York Heart Association class II, III, or IV congestive heart failure
- Uncontrolled asthma
- Interstitial lung disease
- Current use of steroids
- Having been told by a physician to only do exercise prescribed by a physician
- Dementia or organic brain syndrome
- Schizophrenia or active psychosis
- Connective tissue or rheumatologic disease [i.e., Systemic lupus erythematosus, rheumatoid arthritis, amyloidosis, Reiter's syndrome, psoriatic arthritis, mixed connective tissue disease, Sjögren's syndrome, progressive systemic sclerosis, CREST syndrome, polymyositis, dermatomyositis, vasculitis, polymyalgia rheumatic, temporal arteritis]
- Anticipates undergoing elective surgery during the duration of the intervention which would interfere with intervention participation (e.g., breast reconstructive surgery).
- Do not live or work less than 50 miles from the study site
- Lack of transportation to the study site
- Changes in usual medications expected during the study time period
- Plan to move residence out of the local area during the 5 months of the study
- Plan to travel out of the local area for vacation during the first 4 weeks of the intervention or plan to travel out of the local area for more than a week during the last 8 weeks of the intervention
- Contraindication to participation in physical activity (i.e., moderate intensity walking and strength training with resistance bands)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Ingen inngripen: Control
no physical activity intervention
|
|
Eksperimentell: Exercise intervention
3 month physical activity intervention involving moderate intensity walking and strength training with resistance bands
|
3 month physical activity intervention involving moderate intensity walking and strength training with resistance bands
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
physical activity
Tidsramme: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in physical activity, before and after participation in a physical activity intervention.
Participants are in the study for approximately 5 months.
Assessments will be conducted at baseline, and following the 3 month exercise intervention.
|
baseline and 3 months
|
muscle strength
Tidsramme: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in muscle strength before and after participation in a physical activity intervention.
|
baseline and 3 months
|
fatigue
Tidsramme: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in fatigue before and after participation in a physical activity intervention.
|
baseline and 3 months
|
sleep dysfunction
Tidsramme: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in sleep dysfunction before and after participation in a physical activity intervention.
|
baseline and 3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
inflammatory markers (serum cytokine levels)
Tidsramme: baseline and 3 months
|
The study will also examine whether changes in inflammatory markers mediate improvements in the outcome measures of muscle strength, fatigue, and sleep dysfunction.
Blood samples with no potential for extraction of DNA will be collected.
|
baseline and 3 months
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Rogers LQ, Vicari S, Trammell R, Hopkins-Price P, Fogleman A, Spenner A, Rao K, Courneya KS, Hoelzer KS, Robbs R, Verhulst S. Biobehavioral factors mediate exercise effects on fatigue in breast cancer survivors. Med Sci Sports Exerc. 2014 Jun;46(6):1077-88. doi: 10.1249/MSS.0000000000000210.
- Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Spenner A, Vicari S, Rao K, Courneya KS, Hoelzer K, Robbs R, Verhulst S. Inflammation and psychosocial factors mediate exercise effects on sleep quality in breast cancer survivors: pilot randomized controlled trial. Psychooncology. 2015 Mar;24(3):302-10. doi: 10.1002/pon.3594. Epub 2014 Jun 11.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- ROG-SCCI-10-004-1
- R21CA135017-01A2 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Brystkreft
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital og andre samarbeidspartnereFullførtThe Clinical Application Guide of Conebeam Breast CTKina
-
Novartis PharmaceuticalsFullførtMetastatisk brystkreft (MBC) | Locally Advance Breast Cancer (LABC)Storbritannia, Spania
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkjentHR-positiv, HER2-negativ og PIK3CA Mutation Advanced Breast CancerKina
-
Emory UniversityNational Cancer Institute (NCI)TilbaketrukketPrognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i hjernen | Metastatisk brystkarsinom | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeAnatomisk stadium IV brystkreft AJCC v8 | Prognostisk stadium IV brystkreft AJCC v8 | Metastatisk malign neoplasma i beinet | Metastatisk malign neoplasma i lymfeknutene | Metastatisk malign neoplasma i leveren | Metastatisk brystkarsinom | Metastatisk malign neoplasma i lungen | Metastatisk malign neoplasma... og andre forholdForente stater, Canada, Saudi-Arabia, Korea, Republikken
Kliniske studier på 3 month physical activity intervention
-
The Miriam HospitalUkjentSlag | Stillesittende livsstil | Iskemisk angrep, forbigående | TreningForente stater
-
Lucas CarrUniversity of IowaFullført
-
Halic UniversityFullførtSøvninitiering og vedlikeholdsforstyrrelserTyrkia
-
IVI BilbaoInstituto Valenciano de Infertilidad, IVI VALENCIAFullført
-
University of Massachusetts, WorcesterEunice Kennedy Shriver National Institute of Child Health and Human Development... og andre samarbeidspartnereFullført
-
Cairo UniversityPåmelding etter invitasjon
-
Istanbul Kültür UniversityMarmara University; Istanbul University - Cerrahpasa (IUC)FullførtFysisk aktivitet | Parkinsons sykdom | Balansere | Fallende | KinesiofobiTyrkia
-
Istanbul Kültür UniversityTilbaketrukketFysisk aktivitetsnivå | Bevissthet om fysisk aktivitet
-
University of Colorado, DenverNational Institute of Nursing Research (NINR)FullførtAutismespektrumforstyrrelse | Barneutviklingsforstyrrelser, gjennomgripende
-
Nigde Omer Halisdemir UniversityPamukkale UniversityFullført